Financhill
Sell
34

PTCT Quote, Financials, Valuation and Earnings

Last price:
$45.36
Seasonality move :
7.01%
Day range:
$44.74 - $47.42
52-week range:
$23.58 - $54.16
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.92x
P/B ratio:
--
Volume:
1.3M
Avg. volume:
868.6K
1-year change:
71.01%
Market cap:
$3.6B
Revenue:
$937.8M
EPS (TTM):
-$5.94

PTC Therapeutics SEC Filings

Company Filed Form Type Description
PTCT
PTC Therapeutics
04/25/2024 10-Q 10-Q filing on 04/25/2024 View Form
PTCT
PTC Therapeutics
10/26/2023 10-Q 10-Q filing on 10/26/2023 View Form
PTCT
PTC Therapeutics
08/03/2023 10-Q 10-Q filing on 08/03/2023 View Form
PTCT
PTC Therapeutics
04/27/2023 10-Q 10-Q filing on 04/27/2023 View Form
PTCT
PTC Therapeutics
10/27/2022 10-Q 10-Q filing on 10/27/2022 View Form
PTCT
PTC Therapeutics
08/04/2022 10-Q 10-Q filing on 08/04/2022 View Form
PTCT
PTC Therapeutics
05/03/2022 10-Q 10-Q filing on 05/03/2022 View Form
PTCT
PTC Therapeutics
10/28/2021 10-Q 10-Q filing on 10/28/2021 View Form
PTCT
PTC Therapeutics
07/29/2021 10-Q 10-Q filing on 07/29/2021 View Form
PTCT
PTC Therapeutics
05/04/2021 10-Q 10-Q filing on 05/04/2021 View Form
PTCT
PTC Therapeutics
10/29/2020 10-Q 10-Q filing on 10/29/2020 View Form
PTCT
PTC Therapeutics
08/05/2020 10-Q 10-Q filing on 08/05/2020 View Form
PTCT
PTC Therapeutics
04/30/2020 10-Q 10-Q filing on 04/30/2020 View Form
PTCT
PTC Therapeutics
03/02/2020 10-K 10-K filing on 03/02/2020 View Form
PTCT
PTC Therapeutics
10/30/2019 10-Q 10-Q filing on 10/30/2019 View Form
PTCT
PTC Therapeutics
08/06/2019 10-Q 10-Q filing on 08/06/2019 View Form
PTCT
PTC Therapeutics
05/02/2019 10-Q 10-Q filing on 05/02/2019 View Form
PTCT
PTC Therapeutics
03/01/2019 10-K 10-K filing on 03/01/2019 View Form
PTCT
PTC Therapeutics
11/05/2018 10-Q 10-Q filing on 11/05/2018 View Form
PTCT
PTC Therapeutics
08/07/2018 10-Q 10-Q filing on 08/07/2018 View Form
PTCT
PTC Therapeutics
05/09/2018 10-Q 10-Q filing on 05/09/2018 View Form
PTCT
PTC Therapeutics
03/06/2018 10-K 10-K filing on 03/06/2018 View Form
PTCT
PTC Therapeutics
11/02/2017 10-Q 10-Q filing on 11/02/2017 View Form
PTCT
PTC Therapeutics
08/09/2017 10-Q 10-Q filing on 08/09/2017 View Form
PTCT
PTC Therapeutics
05/08/2017 10-Q 10-Q filing on 05/08/2017 View Form
PTCT
PTC Therapeutics
03/16/2017 10-K 10-K filing on 03/16/2017 View Form
PTCT
PTC Therapeutics
11/03/2016 10-Q 10-Q filing on 11/03/2016 View Form
PTCT
PTC Therapeutics
08/04/2016 10-Q 10-Q filing on 08/04/2016 View Form
PTCT
PTC Therapeutics
05/05/2016 10-Q 10-Q filing on 05/05/2016 View Form
PTCT
PTC Therapeutics
02/29/2016 10-K 10-K filing on 02/29/2016 View Form
PTCT
PTC Therapeutics
11/09/2015 10-Q 10-Q filing on 11/09/2015 View Form
PTCT
PTC Therapeutics
07/31/2015 10-Q 10-Q filing on 07/31/2015 View Form
PTCT
PTC Therapeutics
05/05/2015 10-Q 10-Q filing on 05/05/2015 View Form
PTCT
PTC Therapeutics
03/02/2015 10-K 10-K filing on 03/02/2015 View Form

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

NVIDIA vs Broadcom Stock: Which Is Best?
NVIDIA vs Broadcom Stock: Which Is Best?

If you want to invest in an AI-leading tech company,…

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is up 5.12% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 8.05% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 4.14% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock